Department of Nephrology, University of Munich, Germany.
Am J Pathol. 2009 Nov;175(5):1896-904. doi: 10.2353/ajpath.2009.090182. Epub 2009 Oct 15.
Viral DNA induces potent antiviral immunity by activating dendritic cells; however, the mechanism governing viral DNA-mediated triggering or aggravation of glomerulonephritis is unknown. Glomerular endothelial cells (GEnCs) do not express toll-like receptor (TLR)9, the only DNA-specific TLR. We therefore hypothesized that DNA could activate GEnCs via the recently discovered TLR-independent viral DNA recognition pathway. Indeed, double-stranded non-CpG (B-) DNA activated GEnCs to produce interleukin-6, CCL5/RANTES, CCL2/MCP-1, CXCL10/IP10, interferon (IFN)-alpha, and IFN-beta when cationic lipids facilitated intracellular DNA uptake. This cytokine production was inhibited by chlorpromazine, suggesting that clathrin-dependent endocytosis is required for B-DNA entry. However, chloroquine and MyD88 inhibition did not affect GEnC activation, suggesting TLR-independent DNA recognition. In addition, IFN-beta activated cytokine and chemokine mRNA expression, although only CXCL10/IP10 was induced at the protein level, and type I IFN did not activate GEnC in an autocrine-paracrine auto-activation loop. B-DNA complexes induced intercellular adhesion molecule-1 expression at the GEnC surface and increased intercellular adhesion molecule-1-dependent leukocyte adhesion and microvascular extravasation in vivo. Furthermore, B-DNA complexes increased albumin permeability of GEnC monolayers in culture or microvascular dextran leakage in vivo. In addition, B-DNA complexes impaired GEnC proliferation. Thus, complexed B-DNA activates GEnC to produce cytokines, chemokines, and type I IFNs, increases leukocyte adhesion and microvascular permeability, and reduces GEnC proliferation via a MyD88-independent cytosolic DNA recognition pathway. This innate antiviral response program suggests a novel pathomechanism regulating DNA virus-mediated induction or aggravation of glomerulonephritis.
病毒 DNA 通过激活树突状细胞诱导强烈的抗病毒免疫;然而,控制病毒 DNA 介导的肾小球肾炎触发或加重的机制尚不清楚。肾小球内皮细胞 (GEnC) 不表达 Toll 样受体 (TLR)9,这是唯一的 DNA 特异性 TLR。因此,我们假设 DNA 可以通过最近发现的 TLR 非依赖性病毒 DNA 识别途径激活 GEnC。事实上,当阳离子脂质促进细胞内 DNA 摄取时,双链非 CpG (B-) DNA 激活 GEnC 产生白细胞介素-6、CCL5/RANTES、CCL2/MCP-1、CXCL10/IP10、干扰素 (IFN)-α 和 IFN-β。这种细胞因子产生被氯丙嗪抑制,表明网格蛋白依赖的内吞作用是 B-DNA 进入所必需的。然而,氯喹和 MyD88 抑制不影响 GEnC 激活,表明 TLR 非依赖性 DNA 识别。此外,IFN-β 激活细胞因子和趋化因子 mRNA 表达,尽管仅诱导 CXCL10/IP10 蛋白水平,并且 I 型 IFN 不会在自分泌-旁分泌自激活环中激活 GEnC。B-DNA 复合物诱导 GEnC 表面细胞间黏附分子-1 的表达,并增加细胞间黏附分子-1 依赖性白细胞黏附和体内微血管渗出。此外,B-DNA 复合物增加 GEnC 单层培养物中的白蛋白通透性或体内微血管右旋糖酐渗漏。此外,B-DNA 复合物抑制 GEnC 增殖。因此,复合 B-DNA 通过一种 MyD88 非依赖性胞质 DNA 识别途径激活 GEnC 产生细胞因子、趋化因子和 I 型 IFNs,增加白细胞黏附和微血管通透性,并减少 GEnC 增殖。这种先天抗病毒反应程序表明了一种新的病理机制,调节 DNA 病毒介导的肾小球肾炎的诱导或加重。